Overview
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. In the WikiBiome context, GABA is notable because gut bacteria produce it — certain Lactobacillus and Bifidobacterium species possess glutamate decarboxylase (GAD) enzymes that convert dietary glutamate to GABA. This microbial GABA production links the gut brain axis to anxiety, depression, PMDD, and schizophrenia.
Microbial GABA Production
- lactobacillus reuteri, L. brevis, and bifidobacterium species are the primary GABA-producing gut bacteria.
- Microbial GABA acts locally on enteric neurons (vagal afferents) and may contribute to circulating GABA levels.
- Dysbiosis-driven loss of GABA-producing commensals is associated with anxiety and depressive phenotypes [1].
Disease Associations
- PMDD/PMS: GABAergic deficiency implicated in premenstrual mood dysregulation; allopregnanolone (a GABA-A receptor modulator) is central to PMDD pathophysiology [2] [3] [4].
- Schizophrenia: Altered GABA levels and GABAergic signaling in schizophrenia gut-brain axis [5] [6].
- MS: Dietary interventions targeting GABA pathways in multiple sclerosis [7].
Cross-References
- gut brain axis — GABA as microbial-derived neuroactive metabolite
- serotonin — complementary neurotransmitter in gut-brain signaling
- allopregnanolone — GABA-A modulator central to PMDD
- lactobacillus reuteri — GABA-producing commensal
- bifidobacterium — GABA-producing commensal
- neuroinflammation — GABAergic loss compounds neuroinflammatory damage